Imatinib, a ground breaking drug in cancer treatment, has dramatically improved outcomes for patients with certain types of cancer. It is most notably used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumours (GIST). As a targeted therapy, Imatinib works by inhibiting specific proteins, like BCR-ABL in CML and c-Kit in GIST, which are responsible for...